ClinicalTrials.Veeva

Menu

OCTA Changes in Choroidal Neovascularization in High Myopia

S

Sohag University

Status

Not yet enrolling

Conditions

Myopic Choroidal Neovascularisation

Treatments

Device: OCTA

Study type

Observational

Funder types

Other

Identifiers

NCT06357559
OCTA in Myopic CNV

Details and patient eligibility

About

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV..

Full description

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV.. regarding the size , shape , core , margin , Appearance , and activity of CNV..

Enrollment

100 estimated patients

Sex

All

Ages

10 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All Patients with High Myopia ( > -6 D or Axial Length > 26.5 mm ) with Fundoscopic Changes Consistent with CNVM , with Clear Media are Subjected to OCTA

Exclusion criteria

  • Patients with Treated CNVs , or with other Causes of CNVs including :

Neovascular AMD , Idiopathic CNV , Traumatic , Inflammatory , Neoplastic , Degenerative ..

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed Hamdy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems